India’s Medical Value Travel (MVT) sector is projected to more than double from its 2022 valuation of US$ 6 billion to surpass US$ 13 billion by the end of 2026. Speaking at the 8th edition of Advantage Healthcare India (AHCI) 2026, Union Minister Gajendra Singh Shekhawat highlighted that India has emerged as a premier global hub for healthcare due to its unique integration of modern medicine with traditional AYUSH systems and a streamlined medical visa process.
Under the "Heal in India" initiative, the government is focusing on building "Integrated Medical and Wellness Hubs" and enhancing institutional discipline to ensure international credibility. The 2026 growth trajectory is supported by a shift from fragmented experiences to a structured, organized ecosystem that prioritizes clinical excellence, data integrity, and "Heal with Compassion" ethics, positioning India as the world's most trusted destination for holistic healing.
Key Points:
Integrated Healthcare Ecosystem: Combining world-class modern surgery with traditional AYUSH wellness systems to provide a comprehensive patient experience.
Institutional Discipline & Data Integrity: Emphasizing stronger internal documentation and compliance standards to meet the high expectations of international medical insurance providers.
Streamlined Facilitation: Expanding the "Heal in India" portal and medical visa processes to reduce administrative friction for foreign patients.
Wellness & Medical Hubs: Developing specialized zones that offer both acute medical care and post-operative recovery through traditional wellness practices.
Accreditation & Benchmarking: Utilizing the FICCI Medical Value Travel Awards to benchmark excellence across hospitals, facilitators, and wellness providers.
What is "Medical Value Travel (MVT)"? Medical Value Travel (MVT) refers to the practice of people traveling across international borders to receive medical, dental, or surgical care while also utilizing wellness and restorative services. In the Indian context, MVT is a "Champion Sector" that leverages the country's cost advantage and clinical expertise. Unlike generic "medical tourism," MVT focuses on the "Value" proposition—ensuring that patients receive not just a surgery, but a high-integrity, Compassion-led healing journey. By standardizing "Technical Fidelity" in healthcare delivery through international accreditations (like JCI and NABH), India ensures that its MVT ecosystem matches global credibility standards, attracting patients for complex procedures ranging from organ transplants to robotic surgeries.
Policy Relevance
For India, MVT represents a transition from "Ad-hoc Patient Intake" to "Global Healthcare Stewardship," essential for funding the domestic medical infrastructure under Viksit Bharat@2047.
Sovereign Healthcare Resilience: Capturing US$ 13 billion in foreign exchange through MVT provides the fiscal space for the government to reinvest in public health infrastructure, matching the "Implementation Fidelity" seen in the PMAY-U and urban planning reforms.
Operationalizing "Heal in India": The integration of modern and traditional systems allows India to bypass the limitations of single-model healthcare, providing a unique Wellness + Medicine hybrid that is in high global demand.
Documentation as a Trade Barrier: The emphasis on "internal documentation and data integrity" is the primary mechanic for overcoming the historical rejection of Indian medical claims by foreign insurance providers.
The "Champion Sector" Multiplier: By transitioning from a fragmented experience to an organized one, India is essentially creating a "Special Economic Zone" for services, where clinical excellence is the primary export commodity.
Holistic Competitive Edge: The integration of AYUSH is not just cultural; it is a strategic "Product Differentiation" that allows India to offer long-term rehabilitation packages that pure-allopathic hubs (like Thailand or Turkey) cannot easily replicate.
Relevant Question for Policy Stakeholders: What are the 'Clinical-AYUSH Interoperability' standards needed to ensure that a patient’s surgical data from an allopathic wing is seamlessly utilized by practitioners in the traditional wellness wing?
Follow the full update here: Indian MVT to surpass $13 bn by 2026
